Varex Imaging Corporation (VREX)

In the past six months, Varex Imaging Corp.'s stock has trended upwards by 44.28%. Key events impacting the stock price include strong Q2 and Q3 2025 earnings, significant orders for cargo inspection systems, tariff reductions in China leading to resumed delivery requests, product launches such as Lumen HD and THOR detectors, a manufacturing agreement with Nanox, and a pricing agreement renewal with Canon Medical Systems.

Demand for Varex Imaging Corp.'s products is influenced by healthcare spending trends, regulatory approvals, and adoption rates of industrial technologies. The medical segment is affected by healthcare spending cycles, while the industrial segment sees strong demand for security screening. Tariff policies can introduce fluctuations in demand from specific regions. Replacement and service of existing equipment provide a stable revenue stream.

Varex Imaging Corporation is an innovator, designer, and manufacturer of X-ray imaging components, operating through its Medical and Industrial segments. The Medical segment offers X-ray tubes, digital detectors, software, and other components for medical applications like CT and mammography. The Industrial segment provides X-ray imaging products for security and inspection, including Linatron X-ray linear accelerators and digital detectors used in baggage and cargo screening. Varex produces approximately 27,000 X-ray tubes and 20,000 X-ray detectors annually.

Varex Imaging Corporation has a significant global presence with its headquarters in Salt Lake City, Utah, USA. It has manufacturing facilities in the US, the Netherlands, the UK, China, India, Germany, Finland, and the Philippines. Varex maintains an operational presence across the Americas, Europe, Russia, the Middle East, Africa, Asia, and Australia, and employs people across five continents.

Varex Imaging's brand reputation in the past year appears positive, driven by product innovation, strategic collaborations, and strong financial performance. The launch of advanced detectors and partnership with Nanox enhance its image. Positive earnings reports contribute to a favorable reputation among investors. However, a significant decrease in net income and a leadership transition plan could potentially impact investor sentiment.

Varex Imaging Corporation's ownership is a mix of institutional, retail, and individual investors. Institutional investors hold approximately 27.47% to 74.29% of the stock, with major holders including Pzena Investment Management Llc, BlackRock, Inc., and Vanguard Group Inc. Insiders own approximately 1.28% of the stock. Retail investors hold approximately 55.35% of the stock.